EDIT is Editas Medicine, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.08. Market cap: $473M. Capital Quality Rank: 61/100 — Above average.
Stock snapshot
| Price | $3.08 |
| Market cap | $473M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 61 / 100 · Above average |
| Revenue CAGR (3y) | 27.2% |
| Shareholder buyback yield | -7.22% |
| Altman Z-score zone | Distress |
About EDIT
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
Related non-dividend companies
Other non-dividend stocks investors research alongside EDIT. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is EDIT's current stock price?
EDIT (Editas Medicine, Inc.) is currently trading at $3.08.
Does EDIT pay a dividend?
EDIT (Editas Medicine, Inc.) does not currently pay a regular dividend.
What is EDIT's Capital Quality Rank?
EDIT has a Capital Quality Rank of 61/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track EDIT in DiviDrip
Add EDIT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search EDIT and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.